Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
2.200
+0.080 (3.77%)
At close: Jan 29, 2026, 4:00 PM EST
2.190
-0.010 (-0.45%)
Pre-market: Jan 30, 2026, 8:16 AM EST
Neuronetics Market Cap
Neuronetics has a market cap or net worth of $150.67 million as of January 30, 2026. Its market cap has increased by 15.70% in one year.
Market Cap
150.67M
Enterprise Value
213.45M
1-Year Change
15.70%
Ranking
Category
Stock Price
$2.20
Market Cap Chart
Since June 28, 2018, Neuronetics's market cap has decreased from $464.84M to $150.67M, a decrease of -67.59%. That is a compound annual growth rate of -13.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 145.19M | 53.62% |
| Dec 31, 2025 | 94.51M | 5.48% |
| Dec 31, 2024 | 89.60M | 6.79% |
| Dec 29, 2023 | 83.91M | -55.13% |
| Dec 30, 2022 | 187.01M | 59.02% |
| Dec 31, 2021 | 117.60M | -44.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CVRx, Inc. | 197.62M |
| Rapid Micro Biosystems | 188.37M |
| InfuSystem Holdings | 172.45M |
| Apyx Medical | 171.91M |
| Lucid Diagnostics | 167.97M |
| Treace Medical Concepts | 161.84M |
| Inogen | 159.90M |
| LENSAR | 149.07M |